Ultrathin Hydrocolloid Dressing in Skin Damaged From Alternating Radiotherapy and Chemotherapy Plus Cetuximab in Advanced Head and Neck Cancer (G.O.N.O. AlteRCC Italian Trial): In Regard to Macmillan et al. (Int J Radiat Oncol Biol Phys 2007;68:864-872)

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 2, 2007, Pages 638-639

  Russi, Elvio G ^a   Merlano, Marco C ^a   Comino, Alberto ^a   Numico, Gianmauro ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CETUXIMAB;

BURNING SENSATION; HEAD AND NECK CANCER; HUMAN; HYDROGEL; LETTER; PAIN; PRIORITY JOURNAL; PRURITUS; SKIN DEFECT;

CARBOXYMETHYLCELLULOSE; DERMATOLOGIC AGENTS; HUMANS; HYDROGELS; OCCLUSIVE DRESSINGS; RADIODERMATITIS; TREATMENT OUTCOME; WOUND HEALING;

EID: 34548494175     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.05.063     Document Type: Letter

References (4)

1. Macmillan M.S., Wells M., MacBride S., et al. Randomized comparison of dry dressings versus hydrogel in management of radiation-induced moist desquamation. Int J Radiat Oncol Biol Phys 68 (2007) 864-872
2. Merlano MC, Numico G, Colantonio I, et al. AlteRCC phase I-II trial: Alternating radiotherapy and chemotherapy plus cetuximab in advanced head and neck cancer (HNC) [abstract]. J Clin Oncol (meeting abstracts) 2006;24(Suppl.):15515.
3. Wells M., and MacBride S. Radiation skin reactions. In: Faithfull S., and Wells M. (Eds). Supportive care in radiotherapy (2003), Churchill Livingstone, Edinburgh 135-159
4. RTOG Protocol No. 0234. A phase II randomized trial of surgery followed by chemoradiotherapy plus C225 (Cetuximab) for advanced squamous cell carcinoma of the head and neck. Study progress reports. In: Group Meeting Reports February 1-4, 2007, Tampa Marriott Waterside, Tampa, FL. Available online at: www.rtog.org/meeting/RTOG_Mtg_Book_Feb_2007.pdf. Accessed April 7, 2007.